212 related articles for article (PubMed ID: 27256803)
21. Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.
Maganti HB; Jrade H; Cafariello C; Manias Rothberg JL; Porter CJ; Yockell-Lelièvre J; Battaion HL; Khan ST; Howard JP; Li Y; Grzybowski AT; Sabri E; Ruthenburg AJ; Dilworth FJ; Perkins TJ; Sabloff M; Ito CY; Stanford WL
Cancer Discov; 2018 Nov; 8(11):1376-1389. PubMed ID: 30115703
[TBL] [Abstract][Full Text] [Related]
22. Ribosomal protein S2 interplays with MDM2 to induce p53.
Cho J; Park J; Shin SC; Kim JH; Kim EE; Song EJ
Biochem Biophys Res Commun; 2020 Mar; 523(2):542-547. PubMed ID: 31928715
[TBL] [Abstract][Full Text] [Related]
23. Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop.
He X; Li Y; Dai MS; Sun XX
Oncotarget; 2016 Mar; 7(13):16217-26. PubMed ID: 26908445
[TBL] [Abstract][Full Text] [Related]
24. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
[TBL] [Abstract][Full Text] [Related]
25. Ribosomal stress induces L11- and p53-dependent apoptosis in mouse pluripotent stem cells.
Morgado-Palacin L; Llanos S; Serrano M
Cell Cycle; 2012 Feb; 11(3):503-10. PubMed ID: 22262176
[TBL] [Abstract][Full Text] [Related]
26. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
28. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.
Bursać S; Brdovčak MC; Pfannkuchen M; Orsolić I; Golomb L; Zhu Y; Katz C; Daftuar L; Grabušić K; Vukelić I; Filić V; Oren M; Prives C; Volarevic S
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20467-72. PubMed ID: 23169665
[TBL] [Abstract][Full Text] [Related]
29. Guarding the 'translation apparatus': defective ribosome biogenesis and the p53 signaling pathway.
Chakraborty A; Uechi T; Kenmochi N
Wiley Interdiscip Rev RNA; 2011; 2(4):507-22. PubMed ID: 21957040
[TBL] [Abstract][Full Text] [Related]
30. The RP-Mdm2-p53 pathway and tumorigenesis.
Miliani de Marval PL; Zhang Y
Oncotarget; 2011 Mar; 2(3):234-8. PubMed ID: 21406728
[TBL] [Abstract][Full Text] [Related]
31. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint.
Donati G; Peddigari S; Mercer CA; Thomas G
Cell Rep; 2013 Jul; 4(1):87-98. PubMed ID: 23831031
[TBL] [Abstract][Full Text] [Related]
32. Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest.
Kim HD; Kim TS; Kim J
Oncogene; 2011 Jul; 30(30):3317-27. PubMed ID: 21383696
[TBL] [Abstract][Full Text] [Related]
33. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway.
Horn HF; Vousden KH
Oncogene; 2008 Oct; 27(44):5774-84. PubMed ID: 18560357
[TBL] [Abstract][Full Text] [Related]
34. Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice.
Pourebrahim R; Montoya RH; Akiyama H; Ostermann L; Khazaei S; Muftuoglu M; Baran N; Zhao R; Lesluyes T; Liu B; Khoury JD; Gagea M; Van Loo P; Andreeff M
Cell Rep Med; 2024 May; 5(5):101558. PubMed ID: 38733986
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint.
Oršolić I; Bursać S; Jurada D; Drmić Hofman I; Dembić Z; Bartek J; Mihalek I; Volarević S
Oncogene; 2020 Apr; 39(17):3443-3457. PubMed ID: 32108164
[TBL] [Abstract][Full Text] [Related]
36. Signaling to p53: ribosomal proteins find their way.
Zhang Y; Lu H
Cancer Cell; 2009 Nov; 16(5):369-77. PubMed ID: 19878869
[TBL] [Abstract][Full Text] [Related]
37. Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation.
Liu Y; He Y; Jin A; Tikunov AP; Zhou L; Tollini LA; Leslie P; Kim TH; Li LO; Coleman RA; Gu Z; Chen YQ; Macdonald JM; Graves LM; Zhang Y
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):E2414-22. PubMed ID: 24872453
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress.
Xie N; Ma L; Zhu F; Zhao W; Tian F; Yuan F; Fu J; Huang D; Lv C; Tong T
Sci Rep; 2016 Nov; 6():36171. PubMed ID: 27811966
[TBL] [Abstract][Full Text] [Related]
39. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
[TBL] [Abstract][Full Text] [Related]
40. Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress.
Russo A; Russo G
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
